Condition: Acute Myeloid Leukemia, Adult · Sponsor: Sunshine Lake Pharma Co., Ltd.
This is a multi-center open clinical study aimed at evaluating the efficacy and safety of Clifutinib Besylate combined with chemotherapy in newly-treated adult subjects with AML
This description comes directly from the study's public registry record.
Jie Jin, Doctor · 0571-87236685 · jiej0503@163.com
Always discuss trial participation with your own doctor first.
| the First Affiliated Hospital,College of Medicine,Zhejiang University | Hanzhou, Zhejiang, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05133882